Associations of cardiac stress biomarkers with incident type 2 diabetes and changes in glucose metabolism: KORA F4/FF4 study

被引：0

作者：

Chaterina Sujana

Jochen Seissler

Jens Jordan

Wolfgang Rathmann

Wolfgang Koenig

Michael Roden

Ulrich Mansmann

Christian Herder

Annette Peters

Barbara Thorand

Cornelia Then

机构：

[1] Helmholtz Zentrum München-German Research Centre for Environmental Health,Institute of Epidemiology

[2] Ludwig-Maximilians-Universität,Institute for Medical Information Processing, Biometry, and Epidemiology (IBE)

[3] Pettenkofer School of Public Health,Medizinische Klinik und Poliklinik IV, Klinikum der Universität München

[4] Ludwig-Maximilians-Universität,Division of Endocrinology and Diabetology, Medical Faculty

[5] Institute of Aerospace Medicine,undefined

[6] German Aerospace Center (DLR) and University of Cologne,undefined

[7] Institute for Biometrics and Epidemiology,undefined

[8] German Diabetes Center,undefined

[9] Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf,undefined

[10] German Center for Diabetes Research (DZD),undefined

[11] Deutsches Herzzentrum München,undefined

[12] Technische Universität München,undefined

[13] German Centre for Cardiovascular Research (DZHK),undefined

[14] Partner Site Munich Heart Alliance,undefined

[15] Institute of Epidemiology and Medical Biometry,undefined

[16] University of Ulm,undefined

[17] Institute for Clinical Diabetology,undefined

[18] German Diabetes Center,undefined

[19] Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf,undefined

[20] Heinrich Heine University Düsseldorf,undefined

来源：

Cardiovascular Diabetology | / 19卷

关键词：

MR-proANP; Copeptin; CT-proET-1; MR-proADM; Cardiac stress biomarkers; Type 2 diabetes; Prediabetes; Insulin resistance; Incidence; Cohort study;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 246 条

[1]

Bell DS(2003)Heart failure: the frequent, forgotten, and often fatal complication of diabetes Diabetes Care 26 2433-2441

[2]

Wang TJ(2007)Association of plasma natriuretic peptide levels with metabolic risk factors in ambulatory individuals Circulation 115 1345-1353

[3]

Larson MG(2004)Impact of obesity on plasma natriuretic peptide levels Circulation 109 594-600

[4]

Keyes MJ(2013)Plasma MR-proANP levels are associated with carotid intima-media thickness in the general community: the KORA F4 study Atherosclerosis. 230 235-241

[5]

Levy D(2012)Vasoregulatory peptides pro-endothelin-1 and pro-adrenomedullin are associated with metabolic syndrome in the population-based KORA F4 study Eur J Endocrinol 167 847-853

[6]

Benjamin EJ(2009)Plasma carboxy-terminal provasopressin (copeptin): a novel marker of insulin resistance and metabolic syndrome J Clin Endocrinol Metab. 94 2558-2564

[7]

Vasan RS(2020)Relation of copeptin with diabetic and renal function markers among patients with diabetes mellitus progressing towards diabetic nephropathy Arch Med Res. 51 548-555

[8]

Wang TJ(2010)Thirty-one novel biomarkers as predictors for clinically incident diabetes PLoS ONE 5 e10100-1497

[9]

Larson MG(2016)Longitudinal assessment of N-terminal pro-B-type natriuretic peptide and risk of diabetes in older adults: the cardiovascular health study Metab Clin Exp 65 1489-645

[10]

Levy D(2011)Mendelian randomization study of B-type natriuretic peptide and type 2 diabetes: evidence of causal association from population studies PLoS Med. 8 e1001112-32

← 1 2 3 4 5 6 7 8 9 10 →